Nadroparin PSK

Cardiology

Nadroparin PSK

Registration certificate:

INN:

Nadroparin Calcium

Release form:

Solution for injection

Therapeutic Area:

Cardiology

Pharmacotherapeutic Group:

Direct-acting anticoagulant

Conditions for dispensing:

On prescription

Packaging:

Indications for Use:

Prevention of thromboembolic complications:
- During general and orthopedic surgeries.
- In patients with a high risk of thromboembolism (acute respiratory failure and/or respiratory infection, and/or heart failure), especially those bedridden due to acute therapeutic conditions or hospitalized in intensive care units.
Treatment of moderate to severe pulmonary embolism or proximal deep vein thrombosis of the lower limbs.
Prevention of blood clotting during hemodialysis.
Treatment of unstable angina and non-Q wave myocardial infarction.